This CRO training provide all the specific methodology and management techniques to successfully outsource pharmaceutical programs completed on time, within budget, most importantly completed with high level of quality and performance.
This course will provide the attendees with all the specific methodology and management techniques to successfully outsource pharmaceutical programs, that are completed on time, within budget, and most importantly completed with a high level of quality and performance. Participants will gain an in depth perspective focused on the components of performance and quality based management of drug development. Participants will learn how the current external and internal forces are shaping the way projects will need to be delivered to be competitive and cost efficient, given the state of the industry.
Specific attention will be given to defining meaningful Key Performance Indicators (KPI’s), implementing those indicators into the process, and gathering/analyzing data to proactively deliver quality studies.
Pharmaceutical and Biotechnology research managers and their counterparts in the CRO industry will gain a thorough understanding of how to work together through implementing outsourcing scorecards to achieve successful outsourcing programs.The following issues will be discussed:
Participants will understand:
The processes in managing CROs, including study plans, in-field site visits, preparation for inspections, monitoring evaluation programs, progress and conditions for terminating the services of a CRO will be analyzed along with the overall requirements of data quality assurance. Solutions to problem assessment and correction involving all outsourcing projects along with the legal requirements of sponsors and CROs will be discussed.
Areas Covered in the Webinar:
Learning Objectives:
Ultimately, the challenge facing pharmaceutical companies today is to pursue two seemingly incompatible goals; maintain or increase quality products, while dramatically reducing costs and development lead times.
With those overall goals in mind, participants will learn all the necessary material for identifying and selecting the right CRO for each segment of the research targeted for outsourcing. Pharmaceutical personnel will learn the techniques required for successfully managing CROs and the shared responsibilities required from the sponsor and the service provider. CRO personnel will gain the full understanding of what is expected of them, in the new drug development process.
Who will Benefit:
This webinar is designed for personnel in the Pharmaceutical, Biotechnology, Medical Device and Biologics industries who use Contract Research Organizations (CROs) in the process of developing their products for Healthcare Authority approval globally. Attendees should have a basic knowledge of drug, device or biologics development processes and a need to understand what is involved in outsourcing non-clinical and clinical research to CROs.
Instructor Profile:
Robert J. Russell, For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.